Literature DB >> 27350368

Comprehensive investigation of aberrant microRNA profiling in bladder cancer tissues.

Yanping Wei1, Rongquan He1, Yuzhuang Wu2, Binliang Gan2, Peirong Wu2, Xiaohui Qiu2, Aihua Lan2, Gang Chen1,2, Qiuyan Wang1, Xinggu Lin3, Yingchun Chen4, Zengnan Mo1,5.   

Abstract

There has been accumulative evidence that microRNAs (miRNAs) play essential roles in the tumorigenesis and progression of bladder cancer. However, individual studies and small sample size caused discrepant outcomes. Thus, the current study focused on a comprehensive profiling of all differentially expressed miRNAs in a total of 519 bladder cancer tissue samples, based on miRNA microarray data. Altogether, 11 prioritized miRNAs stated by 21 published microarray datasets, including five down-regulated (miR-133a-3p, miR-1-3p, miR-99a-5p, miR-490-5p, and miR-133b) and six up-regulated candidate miRNAs (miR-182-5p, miR-935, miR-518e-3p, miR-573, miR-100-3p, and miR-3171) were analyzed with vote-counting strategy and a Robust Rank Aggregation method. Subsequently, miRNA in silico target prediction and potential pathway enrichment analysis were performed to investigate the prospective molecular mechanism of miRNAs in the tumorigenesis of bladder cancer. We found that most of the relative pathways of the aberrantly expressed miRNAs found in the current study were closely correlated with different biological processes, cellular components, molecular functions, cancer pathogeneses, and some cell signalings, such as Wnt signaling, insulin/IGF, PI3 kinase, and FGF signaling pathways. Hence, a comprehensive overview on the miRNA expression pattern in bladder cancer tissues was gained by the current study. These miRNAs might be involved in the tumorigenesis and deterioration of bladder cancer.

Entities:  

Keywords:  Bladder cancer; Microarray; Pathway; Profiling; Tissue; microRNA

Mesh:

Substances:

Year:  2016        PMID: 27350368     DOI: 10.1007/s13277-016-5121-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  40 in total

Review 1.  Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.

Authors:  Fei Pan; Hui Mao; Ling Deng; Guangchao Li; Peiliang Geng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer.

Authors:  Tiantian Wang; Jiancheng Yuan; Nenggui Feng; Yuchi Li; Zheguang Lin; Zhimao Jiang; Yaoting Gui
Journal:  Tumour Biol       Date:  2014-10

3.  Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Authors:  Lars Dyrskjøt; Marie S Ostenfeld; Jesper B Bramsen; Asli N Silahtaroglu; Philippe Lamy; Ramshanker Ramanathan; Niels Fristrup; Jens L Jensen; Claus L Andersen; Karsten Zieger; Sakari Kauppinen; Benedicte P Ulhøi; Jørgen Kjems; Michael Borre; Torben F Orntoft
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

4.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

5.  The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.

Authors:  H Yoshino; T Chiyomaru; H Enokida; K Kawakami; S Tatarano; K Nishiyama; N Nohata; N Seki; M Nakagawa
Journal:  Br J Cancer       Date:  2011-02-08       Impact factor: 7.640

6.  Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer.

Authors:  Stephanie Kriebel; Doris Schmidt; Stefan Holdenrieder; Diane Goltz; Glen Kristiansen; Rudolf Moritz; Christian Fisang; Stefan C Müller; Jörg Ellinger
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

7.  MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1.

Authors:  Xiao-Nan Chen; Ke-Feng Wang; Zhen-Qun Xu; Shi-Jie Li; Qiang Liu; Dong-Hui Fu; Xia Wang; Bin Wu
Journal:  Cancer Cell Int       Date:  2014-07-19       Impact factor: 5.722

8.  Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.

Authors:  Hiroshi Hirata; Koji Ueno; Varahram Shahryari; Yuichiro Tanaka; Z Laura Tabatabai; Yuji Hinoda; Rajvir Dahiya
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

9.  miRBase: annotating high confidence microRNAs using deep sequencing data.

Authors:  Ana Kozomara; Sam Griffiths-Jones
Journal:  Nucleic Acids Res       Date:  2013-11-25       Impact factor: 16.971

Review 10.  Diagnostic Value of MicroRNAs for Urologic Cancers: A Systematic Review and Meta-Analysis.

Authors:  Hui Ouyang; Yanzhao Zhou; Li Zhang; Guanxin Shen
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more
  13 in total

1.  The biological functions of target genes in pan-cancers and cell lines were predicted by miR-375 microarray data from GEO database and bioinformatics.

Authors:  Jiang-Hui Zeng; Xu-Zhi Liang; Hui-Hua Lan; Xu Zhu; Xiu-Yun Liang
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

2.  Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study.

Authors:  Li Gao; Sheng-Hua Li; Yi-Xin Tian; Qing-Qing Zhu; Gang Chen; Yu-Yan Pang; Xiao-Hua Hu
Journal:  Onco Targets Ther       Date:  2017-07-20       Impact factor: 4.147

3.  A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.

Authors:  Hai-Wei Liang; Zhi-Hua Ye; Shu-Ya Yin; Wei-Jia Mo; Han-Lin Wang; Jin-Che Zhao; Guo-Mei Liang; Zhen-Bo Feng; Gang Chen; Dian-Zhong Luo
Journal:  Onco Targets Ther       Date:  2017-07-11       Impact factor: 4.147

Review 4.  miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer.

Authors:  Daojiang Li; Lu Xia; Miao Chen; Changwei Lin; Hao Wu; Yi Zhang; Songqing Pan; Xiaorong Li
Journal:  Oncotarget       Date:  2017-07-25

5.  Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.

Authors:  Kai Qu; Xing Zhang; Ting Lin; Tian Liu; Zhixin Wang; Sushun Liu; Lei Zhou; Jichao Wei; Hulin Chang; Ke Li; Zheng Wang; Chang Liu; Zheng Wu
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

Review 6.  Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure.

Authors:  Fan Dong; Tianyuan Xu; Yifan Shen; Shan Zhong; Shanwen Chen; Qiang Ding; Zhoujun Shen
Journal:  Oncotarget       Date:  2017-04-18

7.  MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.

Authors:  Fengling Li; Aihua Liang; Yan Lv; Guohong Liu; Aili Jiang; Peishu Liu
Journal:  Med Sci Monit       Date:  2017-10-28

8.  IL-27 inhibits non-small-cell lung cancer cell metastasis by miR-935 in vitro.

Authors:  Tao Wang; Yifei Chen; Hanxiang Nie; Yi Huang; Yang Zhao; Jiong Yang
Journal:  Onco Targets Ther       Date:  2019-02-21       Impact factor: 4.147

9.  Molecular network-based identification of competing endogenous RNAs in bladder cancer.

Authors:  Wei-Dong Jiang; Ping-Cheng Yuan
Journal:  PLoS One       Date:  2019-08-01       Impact factor: 3.240

10.  Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysis.

Authors:  Zhuo Peng; Longfei Pan; Zequn Niu; Wei Li; Xiaoyan Dang; Lin Wan; Rui Zhang; Shuanying Yang
Journal:  Oncotarget       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.